VAX014, an Oncolytic Therapy, Reduces Adenomas and Modifies Colon Microenvironment in Mouse Model of CRC

Colorectal cancer (CRC) remains the third most common form of cancer and, despite its reduced mortality, results in over 50,000 deaths annually, highlighting the need for novel therapeutic approaches. VAX014 is a novel clinical-stage, oncolytic bacterial minicell-based therapy shown to elicit protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenier, Shea F., Khan, Mohammad W., Reil, Katherine A., Sawaged, Savannah, Tsuji, Shingo, Giacalone, Matthew J., Tian, Mengxi, McGuire, Kathleen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298379/
https://www.ncbi.nlm.nih.gov/pubmed/37373142
http://dx.doi.org/10.3390/ijms24129993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298379/
https://www.ncbi.nlm.nih.gov/pubmed/37373142
http://dx.doi.org/10.3390/ijms24129993

Ejemplares similares